Fortis Healthcare sets dividend record date, outlines TDS norms
Fortis Healthcare has fixed July 24, 2026, as the record date for a final dividend of ₹1 per share, subject to AGM approval. The company outlined TDS rates of 10% for residents with valid PAN and 20% for non-residents or those with inoperative PAN. Shareholders must submit declarations for exemptions or lower tax by August 5, 2026.

*this image is generated using AI for illustrative purposes only.
Fortis Healthcare Limited has fixed Friday, July 24, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹1 per equity share. The dividend, equivalent to 10% of the face value of ₹10 each, is recommended for the financial year 2025-26 and is subject to the approval of members at the 30th Annual General Meeting scheduled for Tuesday, August 11, 2026. The company has intimated that the dividend will be paid subject to the deduction of Tax at Source (TDS) in accordance with the Income Tax Act, 2025.
The Register of Members and Share Transfer Books will remain closed from Saturday, July 25, 2026, to Tuesday, August 11, 2026. Shareholders are requested to ensure that details such as PAN, residential status, category, and bank account information are updated in their demat accounts or folios by submitting Form ISR-1 to the Registrar and Share Transfer Agent, KFin Technologies Limited. To avail benefits of exemption or lower tax deduction, shareholders must submit necessary declarations and supporting documents on or before August 5, 2026.
Tax Deduction Rates
For resident shareholders, tax will be deducted at 10% if a valid PAN is registered. If the shareholder is a specified person or has provided an inoperative PAN, TDS will be deducted at 20%. Resident individuals are exempt from TDS if the aggregate dividend distributed during the financial year does not exceed ₹10,000. Non-resident shareholders, including Foreign Portfolio Investors, face a withholding tax rate of 20% plus applicable surcharge and cess, unless they opt for benefits under the Double Tax Avoidance Agreement (DTAA).
| Shareholder Category | Applicable TDS Rate | Conditions |
|---|---|---|
| Resident (Valid PAN) | 10% | Valid PAN registered |
| Resident (Inoperative/No PAN) | 20% | Specified person or inoperative PAN |
| Non-Resident | 20% + surcharge + cess | Unless DTAA benefit is claimed |
| Resident Individual | Nil | Dividend ≤ ₹10,000 per year |
Compliance and Submission
Shareholders seeking lower or nil TDS must submit self-declarations and documents via the weblink provided by KFin Technologies or via email. Non-resident shareholders claiming DTAA benefits must provide a Tax Residence Certificate, Form 41, and a self-declaration certifying tax residency and eligibility. The company emphasized that it will rely on data available with the depositories and the RTA as of the record date, and no requests for revision of TDS returns will be entertained.
The intimation was made in compliance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Fortis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.65% | +1.67% | -2.61% | +0.48% | +0.96% | +229.92% |
How might the announcement of this final dividend influence Fortis Healthcare's stock liquidity leading up to the record date?
Could this dividend payout signal a shift in Fortis Healthcare's capital allocation strategy for FY 2026-27?
What impact will the updated Income Tax Act, 2025 provisions have on foreign investor appetite for the stock?


































